CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE
| Brand name | PHEXX |
|---|---|
| Active ingredient | CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE |
| Strength | 1%;1.8%;0.4% |
| Dosage form | GEL |
| Route | VAGINAL |
| Modality | Small molecule |
| FDA approval | May 2020 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 11337989 | March 2033 | use U-1 |
| 11992472 | March 2033 | use U-1 |
| 10568855 | March 2033 | use U-1 |
| 11439610 | March 2033 | substance, product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.